Oct 4, 2024

Featuring perspectives from Dr Joshua Brody, Dr Matthew Lunning and Dr Jason Westin, moderated by Dr Lunning, including the following topics:

• Introduction (0:00)
• Integration of Chimeric Antigen Receptor (CAR) T-Cell Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Westin (1:34)
• Current Role of CAR...

Oct 2, 2024

Featuring perspectives from Dr Joshua K Sabari and Dr Helena Yu, including the following topics:

• Introduction: Checkpoint Inhibitors and Lung Cancer with an EGFR Mutation (0:00)
• Current Management of Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations — Dr Sabari (5:39)
• Novel Therapeutic Approaches for...

Sep 25, 2024

Featuring a slide presentation and related discussion from Dr Tiffany A Traina, including the following topics:

• Extended follow-up with pembrolizumab/chemotherapy for patients with previously untreated PD-L1-positive metastatic triple-negative breast cancer (mTNBC) (0:00)
• ASCENT trial: Survival advantage...

Sep 25, 2024

Featuring an interview with Dr Tiffany A Traina, including the following topics:

• Choice of chemotherapy to combine with first-line pembrolizumab for metastatic triple-negative breast cancer (mTNBC) (0:00)
• Ongoing investigations of androgen receptor-targeting agents for metastatic breast cancer (mBC) (8:37)
• Efficacy and...

Sep 20, 2024

Featuring slide presentations and related discussion from Dr Lipika Goyal, Dr James J Harding, Dr Milind Javle and Dr Robin K (Katie) Kelley, including the following topics:

• Current Role of Immunotherapeutic Strategies for Advanced Biliary Tract Cancers (BTCs) — Dr Kelley (0:00)
• Case: A man in his late 60s with...